Calculation method for prompting Alzheimer's disease risk of old men by androgen
Patent Information
- Authority / Receiving Office
- CN · China
- Current Assignee / Owner
- HEBEI MEDICAL UNIVERSITY
- Publication Date
- 2020-07-14
- Estimated Expiration
- Not applicable · inactive patent
Smart Images

Figure 1 
Figure 2 
Figure 3
Abstract
Description
technical field
[0001] The invention relates to a risk calculation method, in particular to a calculation method for androgen prompting the risk of Alzheimer's disease in elderly men. Background technique
[0002] The world's first internationally recognized diagnostic criteria for Alzheimer's Disease (AD) was the NINCDS-ADRDA diagnostic criteria published by the National Association of Neurology and Speech Disorders, Stroke and Alzheimer's Disease and Related Diseases in 1984. Over the past 30 years, as people's understanding of AD disease and the ability to detect its pathophysiological process have improved, the concept of the clinical spectrum of the disease has undergone earth-shaking changes. AD diagnostic criteria are also constantly updated and improved, after NINCDS-ADRDA criteria (1984) - IWG criteria (2007, 2010) - NIA-AA criteria (2011) - IWG2 criteria (2014) 4 stage. Whether it is the NIA-AA criteria or the IWG criteria, there is consensus on the concept of AD...